Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality

SARS-CoV-2 (CoV2) antibody therapies, including COVID-19 convalescent plasma (CCP), monoclonal antibodies, and hyperimmune globulin, are among the leading treatments for individuals with early COVID-19 infection. The functionality of convalescent plasma varies greatly, but the association of antibod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Invest
Hauptverfasser: Morgenlander, William R., Henson, Stephanie N., Monaco, Daniel R., Chen, Athena, Littlefield, Kirsten, Bloch, Evan M., Fujimura, Eric, Ruczinski, Ingo, Crowley, Andrew R., Natarajan, Harini, Butler, Savannah E., Weiner, Joshua A., Li, Mamie Z., Bonny, Tania S., Benner, Sarah E., Balagopal, Ashwin, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C., Eshleman, Susan H., Casadevall, Arturo, Redd, Andrew D., Laeyendecker, Oliver, Ackerman, Margaret E., Pekosz, Andrew, Elledge, Stephen J., Robinson, Matthew, Tobian, Aaron A.R., Larman, H. Benjamin
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Clinical Investigation 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011893/
https://ncbi.nlm.nih.gov/pubmed/33571169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI146927
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge